Safety and Immunogenicity Study of Adenovirus-Vectored, Intranasal Pandemic Influenza Vaccine.

This study is enrolling participants by invitation only.

Study NCT00755703 Information provided by Vaxin Inc.

First Received: September 17, 2008 Last Updated: January 8, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is enrolling participants by invitation only.
Estimated Study Completion Date:	April 2011
Estimated Primary Completion Date:	April 2009 (Final data collection date for primary outcome measure)